Literature DB >> 26596360

Clinical relevance of cone beam computed tomography in mandibular third molar removal: A multicentre, randomised, controlled trial.

H Ghaeminia1, N L Gerlach2, Th J M Hoppenreijs3, M Kicken4, J P Dings5, W A Borstlap6, T de Haan7, S J Bergé8, G J Meijer9, T J Maal10.   

Abstract

PURPOSE: The aims of this study were to investigate the effectiveness of cone beam computed tomography (CBCT) compared to panoramic radiography (PR), prior to mandibular third molar removal, in reducing patient morbidity, and to identify risk factors associated with inferior alveolar nerve (IAN) injury.
MATERIAL AND METHODS: This multicentre, randomised, controlled trial was performed at three centres in the Netherlands. Adults with an increased risk for IAN injury, as diagnosed from PR, were included in the study. In one arm of the study, patients underwent an additional CBCT prior to third molar surgery. In a second arm of the study, no additional radiographs were acquired. The primary outcome measure was the number of patient-reported altered sensations 1 week after surgery. As secondary outcome measures, the number of patients with objective IAN injury, with long-term (>6 months) IAN injury, the occurrence of other postoperative complications, the Oral Health Related Quality of Life-14 (OHIP-14) questionnaire responses, postoperative pain (visual analogue scale score), duration of surgery, number of emergency visits, and number of missed days of work or study were scored.
RESULTS: A total of 268 patients with 320 mandibular third molars were analysed according to the intention-to-treat principle. The overall incidence of IAN injury 1 week after surgery was 6.3%. No significant differences between CBCT and PR for temporary IAN injury (p = 0.64) and all other secondary outcomes were registered. A lingual position of the mandibular canal (MC) and narrowing, in which the diameter of the MC lumen was decreased at the contact area between the MC and the roots, were significant risk factors for temporary IAN injury.
CONCLUSION: Although CBCT is a valuable diagnostic adjunct for identification of an increased risk for IAN injury, the use of CBCT does not translate into a reduction of IAN injury and other postoperative complications, after removal of the complete mandibular third molar. In these selected cases of a high risk for IAN injury, an alternative strategy, such as monitoring or a coronectomy, might be more appropriate. (http://clinicaltrials.gov, NCT02071030).
Copyright © 2015 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Complications; Dry socket; Mandibular nerve; Panoramic radiography; Quality of life; Three-dimensional imaging

Mesh:

Year:  2015        PMID: 26596360     DOI: 10.1016/j.jcms.2015.10.009

Source DB:  PubMed          Journal:  J Craniomaxillofac Surg        ISSN: 1010-5182            Impact factor:   2.078


  13 in total

1.  Radiographic signs of pathology determining removal of an impacted mandibular third molar assessed in a panoramic image or CBCT.

Authors:  Louise H Matzen; Lars Schropp; Rubens Spin-Neto; Ann Wenzel
Journal:  Dentomaxillofac Radiol       Date:  2016-10-25       Impact factor: 2.419

Review 2.  Diagnostic accuracy of CBCT compared to panoramic radiography in predicting IAN exposure: a systematic review and meta-analysis.

Authors:  Veronica Caroline Brito Reia; Gabriel de Toledo Telles-Araujo; Mariela Peralta-Mamani; Mariel Ruivo Biancardi; Cássia Maria Fischer Rubira; Izabel Regina Fischer Rubira-Bullen
Journal:  Clin Oral Investig       Date:  2021-07-17       Impact factor: 3.573

3.  Risk stratification against inferior alveolar nerve injury after lower third molar extraction by scoring on cone-beam computed tomography image.

Authors:  Seiko Kubota; Tomoaki Imai; Mitsuhiro Nakazawa; Narikazu Uzawa
Journal:  Odontology       Date:  2019-06-17       Impact factor: 2.634

Review 4.  Cone beam CT imaging of the mandibular third molar: a position paper prepared by the European Academy of DentoMaxilloFacial Radiology (EADMFR).

Authors:  Louise Hauge Matzen; Erwin Berkhout
Journal:  Dentomaxillofac Radiol       Date:  2019-03-05       Impact factor: 2.419

5.  Cone beam CT and treatment decision of mandibular third molars: removal vs. coronectomy-a 3-year audit.

Authors:  Louise Hauge Matzen; Julie Suhr Villefrance; Sven Erik Nørholt; Jesper Bak; Ann Wenzel
Journal:  Dentomaxillofac Radiol       Date:  2019-12-05       Impact factor: 2.419

6.  Panoramic versus CBCT used to reduce inferior alveolar nerve paresthesia after third molar extractions: a systematic review and meta-analysis.

Authors:  Nathalia Calzavara Del Lhano; Rosangela Almeida Ribeiro; Carolina Castro Martins; Neuza Maria Souza Picorelli Assis; Karina Lopes Devito
Journal:  Dentomaxillofac Radiol       Date:  2019-11-28       Impact factor: 2.419

7.  Preoperative Anatomic Evaluation of the Relationship Between Inferior Alveolar Nerve Canal and Impacted Mandibular Third Molar in a Population of Bhubaneswar, Odisha, Using CBCT: A Hospital-Based Study.

Authors:  Rajat Mohanty; Purnendu Rout; Vaibhav Singh
Journal:  J Maxillofac Oral Surg       Date:  2019-02-09

8.  Postoperative socket irrigation with drinking tap water reduces the risk of inflammatory complications following surgical removal of third molars: a multicenter randomized trial.

Authors:  H Ghaeminia; Th J M Hoppenreijs; T Xi; J P Fennis; T J Maal; S J Bergé; G J Meijer
Journal:  Clin Oral Investig       Date:  2016-02-27       Impact factor: 3.573

9.  Hard Tissue Preservation in Minimally Invasive Mandibular Third Molar Surgery Using In Situ Hardening TCP Bone Filler.

Authors:  Wilfried Engelke; Marcio Lazzarini; Víctor Beltrán
Journal:  Biomed Res Int       Date:  2018-11-11       Impact factor: 3.411

10.  Anatomic study of the position of the mandibular canal and corresponding mandibular third molar on cone-beam computed tomography images.

Authors:  Liqun Gu; Chao Zhu; Kejia Chen; Xianchu Liu; Zhangui Tang
Journal:  Surg Radiol Anat       Date:  2017-10-27       Impact factor: 1.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.